Sponsored by: Miller Legal LLP

Find out if you qualify for a lawsuit

Contact Us:
(888) 775-3026(888) 775-3026

Januvia Lawyers

Our Januvia lawyers are currently reviewing possible claims involving Januvia and pancreatic cancer. Studies have shown that the Type 2 diabetes medication may be associated with an increased risk of precancerous changes in the pancreas.

According to reports, there were 292 cases of pancreatic cancer reported to the FDA by patients taking Januvia, Byetta and Victoza during the two year period between Jan. 1, 2010 and June 30, 2012. Our attorneys believe that this risk is serious and we are acting as advocates for affected patients.

How a Januvia Lawyer Can Help You

Pancreatic cancer is a very serious form of cancer that usually isn't detected until the cancer has reached an advanced stage. This is due to the fact that its symptoms generally don't show up until the later stages. At that point, it is often difficult to treat.

A Januvia lawyer can help you get the compensation you need to cover the expensive medical bills associated with having cancer. Our lawyers can also help ensure you get the best medical care possible and that you find answers to questions such as:

  • How will I meet my financial responsibilities?
  • How will I pay my mortgage?
  • How will I continue to support my family?

Our lawyers are familiar with the studies that link Januvia to an increased risk for pancreatic cancer. We have taken a special interest in this connection and feel that Merck should be held accountable. If you or someone you love is diagnosed with this deadly cancer or if you are suffering from another serious side effect of the medication, we may be able to help you.

If you choose to work with one of our attorneys, you can expect that we will:

  • Do everything we can to get you the compensation you need and deserve
  • Make sure that you receive the best medical care possible
  • Make sure that you and your family are well taken care of
  • Always be available to answer any questions you may have
  • Serve as your advocates throughout the entire legal process and after

To find out if you have a claim, contact us today. We can be reached by phone or by email.

Januvia® News

  • Januvia Sales Drop for the Quarter

    May 1st, 2013

    Sales of Merck's Januvia, a diabetes medication and the company's biggest seller, dropped for the first quarter of the year. The news, which was reported May 1, was surprising, Reuters said. Merck also lowered its full-year forecast today. Merck sales for the quarter dropped 9 percent to $10.7 billion, according to reports. That number is well below the $11.09 billion the market was expecting. The drug company... read more

  • Public Citizen Urges FDA to Ban Januvia Because of Cancer Risk

    April 15th, 2013

    Dr. Sidney Wolfe, Director of Public Citizen's Health Research Group, issued a statement last month, addressing the risk of precancerous changes in the pancreases of diabetic patients who use diabetes drugs Januvia (sitagliptin), Byetta (exenatide) and Victoza (liraglutide). According to the statement, Drs. Alexandra Butler and Peter Butler of the University of California, Los Angeles (UCLA) and colleagues published a study in the journal "Diabetes," showing... read more